The UCLA Geriatric Psychiatry Program is conducting an early phase 12-week pilot study to compare the effects of two FDA approved antidepressants: vilazodone and paroxetine for the treatment of geriatric depression. All participants will be given either vilazodone or paroxetine. A complete psychiatric evaluation will be provided. Subjects will not be charged for participation and will be compensated.
If you are interested in participating, please contact us to schedule an appointment or to find out more information: (310) 983-3375 or (310) 794-4619.
*Participants must be 60 years or older and experiencing symptoms of depression